(877) 505-4777| info@speakersnetwork.com

Endocrinology, Diabetes & Metabolism

Director, USC Clinical Diabetes Programs
Professor of Medicine
Keck School of Medicine of USC

Treatment of Type 1 Diabetes
Treatment of Type 2 Diabetes
Insulin Resistance
Diagnosis and Pathophysiology of Diabetes
Diabetic Dyslipidemia
Atherosclerosis in Women: Need for Risk Factor Reduction
Diabetes Prevention
Technology in Diabetes: Meters, Apps, Pumps and Sensors-Present and Future


Chief, Division of Endocrinology, Diabetes and Metabolism
Associate Professor of Medicine
Rutgers New Jersey Medical School

Metabolic Syndrome
Type 1 Diabetes
Type 2 Diabetes
Treating Diabetes in the 21st Century
Managing Cardiovascular Risk in the Diabetes Patient
Adrenal Insufficiency
Diabetic Retinopathy
Managing Endocrine Emergencies

Excellent speakers and very good lecture – St Joseph Regional Medical Center

Assistant Clinical Professor of Diabetes, Endocriniology & Metabolism
City of Hope National Medical Center

Diabetes Update
Diabetes Mellitus
Lipid Metabolism
Vitamin D Deficiency


Clinical Assistant Professor
Division of Endocrinology, Gerontology, and Metabolism
Stanford University Medical Center

Outpatient Management of Type 2 Diabetes
New Diabetes Drugs
Management of Inpatient Diabetes
Endocrine Emergencies
Endocrine Incidentalomas
Diabetes Care for the Primary Care Provider
Adrenal Insufficiency
Testosterone Deficiency / Male Hypogonadism
Hyperthyroidism / Hypothyroidism
Diabetes and Cardiovascular Outcomes


Associate Professor of Medicine
Division of Endocrinology
Keck School of Medicine of USC

Fatigue Among Healthcare Providers and Its Impact on Patient Safety
The Benefits of Music Therapy
Reactive Hypoglycemia, Insulin Resistance, and Prediabetes: What Is the Connection?
Physician Burnout: Causes and Prevention
Diabetic Neuropathy: Most Common Microvascular Disease in Diabetic Population
Hypercalcemia and Hypocalcemia
Diabetic Foot: Number One Reason for Hospitalization of Diabetic Patients
Hypomagnesemia: The Most Neglected Electrolyte Imbalance in Medical Practice
Diabetic Complications: Neuropathy and Gastropathy in Diabetes
Hyperkalemia and Diabetes: A “Deadly Combination”
Insulin Resistance
Metabolic Syndrome
Obesity: A Worker of Insulin Resistance
Stress in Health Care Setting: The Burnout Physician
Stress and Patient Safety: The Impact of Medical Errors
Physician Well-Being: How to Become a “Balanced Physician”
Chocolate: The Perfect Food, What Should We Know about It
Hyporenin Hypoaldosteronism : The Risk of Unrecognized Drug Induced Hyperkalemia
Cushing Syndrome: Diagnosis and Treatment
Hyperaldosteronism: A Common Cause of Hypertension


High-risk Diabetic Patients and Prevention of Cardiovascular Events
Treatment for Diabetic Peripheral Neuropathy
Islet Cell Transplant Program
New Treatment Options for Type 1 and Type 2 Diabetes

Wei Feng, M.D., is a board certified endocrinologist with expertise in many areas such as diabetes, thyroid, pituitary, osteoporosis, PCOS, obesity, lipid disorder, and adrenal disease. She has been a staff physician at the Department of Clinical Diabetes, Endocrinology, and Metabolism at City of Hope since 1998. Born in China, Dr. Feng obtained her medical degree at University of Heidelberg in West Germany in 1987. After completing residency training in internal medicine at University of Memphis in Tennessee, she sought endocrine fellowship training at Cedars Sinai Medical Center. She has diverse clinical experience being hospitalist for a year in 1992 after completing residency training at Memphis Regional Medical Center and a faculty member in the Division of General Internal Medicine at USC between 1995 and 1998. Dr. Feng entered private endocrine practice in year of 2005 in Pasadena while maintaining a part-time position at City of Hope. Now she devotes all her time to the practice of endocrinology at the South Pasadena Cancer Center, which is fully affiliated with the Department of Clinical Diabetes and Endocrinology at the City of Hope. Dr. Feng has been a principal investigator for several clinical trials involving long term studies of intervention for high-risk diabetic patients to prevent cardiovascular events, treatment for diabetic peripheral neuropathy, islet cell transplant program, and new treatment options for type 1 and type 2 diabetes.